{"id":124987,"date":"2026-04-15T12:01:15","date_gmt":"2026-04-15T17:01:15","guid":{"rendered":"https:\/\/media.jamanetwork.com\/?post_type=announcement&p=124987"},"modified":"2026-04-15T12:01:15","modified_gmt":"2026-04-15T17:01:15","slug":"jama-trials-a-new-home-for-clinical-trial-research-and-dialogue","status":"publish","type":"announcement","link":"https:\/\/media.jamanetwork.com\/announcement\/jama-trials-a-new-home-for-clinical-trial-research-and-dialogue\/","title":{"rendered":"JAMA+ Trials: A New Home for Clinical Trial Research and Dialogue"},"content":{"rendered":"

Chicago, IL \u2014 The JAMA Network announces the launch of JAMA+ Trials<\/strong><\/a>, an interdisciplinary platform designed to elevate the visibility, accessibility, and understanding of trusted clinical trial research across medicine.<\/span>\u00a0<\/span><\/p>\n

Alison J. Huang, M.D., M.A.S.<\/span><\/b><\/strong>, Professor of Medicine, Urology, and Epidemiology & Biostatistics at the University of California, San Francisco, <\/span>and Director of Research in the Division of General Internal Medicine at UCSF Health, serves as Editor in Chief of JAMA+ Trials.<\/p>\n

A clinical epidemiologist and trialist, Dr. Huang’s research focuses on improving aging women’s and genitourinary health. She\u00a0has led multiple NIH-, industry-, and foundation-funded randomized trials, developed widely used patient-reported outcome measures, and directs NIH-funded research training programs. She also teaches clinical research and trial methods at UCSF.<\/p>\n

\"clinical<\/a>

Alison J. Huang, M.D., M.A.S., leads JAMA+ Trials as Editor in Chief<\/p><\/div>\n

\u201cBy fostering honest dialogue about the challenges trials face and the transformative evidence they produce, we seek to enhance professional and public understanding of, and ultimately trust in, the clinical trial enterprise,\u201d said Dr.\u00a0Huang.<\/span>\u00a0<\/span><\/p>\n

READ: “A Love Letter to Clinical Trials”<\/a>\u00a0<\/strong><\/em><\/h3>\n

JAMA+ Trials is designed not only for clinical trialists, but also for clinicians, patients, students, and policymakers.\u00a0<\/span><\/p>\n

\n

The initiative includes:<\/p>\n